Rao dermatology offers safe and non-invasive skin cancer detection and treatment methods along with expert staff, which are fully equipped with the latest knowledge and its application.
The step by step detection and treatment is as follows:
The forefront of non-invasive pigmented lesion analysis makes it possible to discern the patterns within moles that help us evaluate their potential for harm. Highly specialized equipment and training allow us to be more selective and more accurate when determining if and when surgery is necessary.
Confocal Microscopy allows for high-resolution, non-invasive imaging of benign and malignant pigmented lesions, non-melanoma skin cancer, and inflammatory skin conditions. Thin sections of tissue can be imaged allowing visualization of the cellular detail without biopsy. These images can then be analyzed by a trained Confocalist. When used appropriately by an expert confocalist, this technology can spare a patient from an unnecessary biopsy or, in some cases, can diagnose melanoma/skin cancer which would not have been detected by the naked eye alone.
After confocal microscopy and analysis, if the lesion is still classified as suspicious, the physician will perform a skin biopsy, which is still the gold standard for diagnosing benign from malignant lesions.
For high risk patients with personal and familial histories of melanoma and other skin cancers, one of the most reliable ways to track new and changing pigmented lesions is with side-by-side comparisons of baseline and follow-up photos.
5MOHS micrographic surgery
The treatment of choice for cancers of the face and other sensitive areas, the MOHS technique allows the physician to precisely identify and remove the entire tumor, leaving surrounding healthy tissue intact and unharmed.
For sun-damaged skin and precancerous actinic keratosis, our patients can take advantage of non-invasive photodynamic therapy (PDT). Unlike biopsies, cryosurgery, or electrodessication, PDT allows for treatment of an entire area of sun damage, reducing the chance that undetected pre-cancerous cells will be left untreated.